1. Chen, Yu, Ohki, Rieko. 2020. p53-PHLDA3-Akt Network: The Key Regulators of Neuroendocrine Tumorigenesis. In International journal of molecular sciences, 21, . doi:10.3390/ijms21114098. https://pubmed.ncbi.nlm.nih.gov/32521808/
2. Takikawa, Masahiro, Ohki, Rieko. 2017. A vicious partnership between AKT and PHLDA3 to facilitate neuroendocrine tumors. In Cancer science, 108, 1101-1108. doi:10.1111/cas.13235. https://pubmed.ncbi.nlm.nih.gov/28295876/
3. Wang, Xiaojing, Li, Jia, Yang, Zhongcheng, Chen, Qiuyun, Wang, Qing K. 2018. phlda3 overexpression impairs specification of hemangioblasts and vascular development. In The FEBS journal, 285, 4071-4081. doi:10.1111/febs.14653. https://pubmed.ncbi.nlm.nih.gov/30188605/
4. Ohki, Rieko, Saito, Kozue, Chen, Yu, Shibata, Tatsuhiro, Nakagama, Hitoshi. 2014. PHLDA3 is a novel tumor suppressor of pancreatic neuroendocrine tumors. In Proceedings of the National Academy of Sciences of the United States of America, 111, E2404-13. doi:10.1073/pnas.1319962111. https://pubmed.ncbi.nlm.nih.gov/24912192/
5. Bensellam, Mohammed, Chan, Jeng Yie, Lee, Kailun, Jonas, Jean-Christophe, Laybutt, D Ross. 2019. Phlda3 regulates beta cell survival during stress. In Scientific reports, 9, 12827. doi:10.1038/s41598-019-49289-5. https://pubmed.ncbi.nlm.nih.gov/31492921/
智鼠故事 
